title: [Combined antibacterial and probiotic therapy of Helicobacter-associated diseases in children].
abstract: On the basis of microbiological monitoring and clinico-morphological criteria, the use of probiotics containing lacto- and bifidobacteria, simultaneously with "triple" antibacterial therapy (antibiotics of choice, metronidazole and bismuth salts), has been found to produce curative effect in the treatment of Helicobacter-associated gastroduodenal pathology in children. The influence of "triple" antibacterial therapy on the microecology of the gastrointestinal tract and the state of the immunobiological status of patients was studied. The combined scheme for correcting damaged microbiocenosis with probiotics in accordance with the concept of microecological adequacy is proposed. The scheme includes modern antibacterial therapy in combination with the probiotic preparations of lactobacteria. The prescription of bifidobacteria-containing probiotics is recommended at early stages from the beginning of etiotropic therapy. The effectiveness of the therapy may be dynamically evaluated, starting from week 5 after the end of the complex therapy, in EIA with the use of specific anti-Helicobacter antibodies.
authors.affiliation: Medical Center of the Administration of the President of the Russian Federation, Moscow.
authors.forename: E A
authors.initials: EA
authors.lastname: Lykova
authors.forename: V M
authors.initials: VM
authors.lastname: Bondarenko
authors.forename: S V
authors.initials: SV
authors.lastname: Sidorenko
authors.forename: M E
authors.initials: ME
authors.lastname: Grishina
authors.forename: A O
authors.initials: AO
authors.lastname: Murashova
authors.forename: V I
authors.initials: VI
authors.lastname: Minaev
authors.forename: F M
authors.initials: FM
authors.lastname: Rytikov
authors.forename: A A
authors.initials: AA
authors.lastname: Korsunskiĭ
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001644:Bifidobacterium; D002648:Child; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005756:Gastritis / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D007778:Lactobacillus; D019936:Probiotics / Q000627:therapeutic use*; D013270:Stomach / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents